GSK Stockmann has provided comprehensive legal advice to L-Rea GmbH on the establishment of a joint venture with the BlueRock Group AG regarding L-Rea GmbH’s subsidiary Residea Immobilien Management GmbH. Since April, the BlueRock Group AG, based in Zurich and Berlin, holds a stake in Residea Immobilien Management GmbH as part of a joint venture.

A team led by Berlin based partner and Corporate/M&A specialist Dr. Thomas Derlin provided comprehensive legal support to L-Rea GmbH regarding this strategic partnership with BlueRock Group AG, in particular in the negotiations and conclusion of the share purchase agreement and the joint venture agreement as well as related corporate and commercial law issues.

Residea Immobilien Management GmbH is a fully integrated asset management company, managing a portfolio of several thousand residential and commercial units, primarily in Berlin. For the real estate investor and asset manager BlueRock Group AG, the participation secures access to qualified management capacities in the demanding Berlin real estate market.

[caption id="attachment_48294" align="alignnone" width="300"] GSK Berlin[/caption]

Advisers of L-Rea at GSK Stockmann:

Dr Thomas Derlin, Dr Andreas C. Peters (both lead, both Corporate/M&A), Dominik Berka (Tax), Jan Kramer (Real Estate) Christina Lorf (Corporate/M&A)

Advisers of Blue Rock Group:

Heussen Rechtsanwaltsgesellschaft mbH: Jan Dittmann, Johannes Weidelener

Notary: Heuking

GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective.

More about us: www.gsk.de/en